Superworth

Organon EPS OGN

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Last 12 months, to Jun 30, 2026
$0.77
Latest quarter, Q2 FY26
$0.40
−29% on a year earlier
Fiscal year 2025
$0.71
−79% on the year before

Organon's earnings per share was $0.77 over the twelve months to Jun 30, 2026, down 71% on a year earlier.

In its latest quarter, Q2 FY26, it was $0.40, down 29% on the same quarter a year before.

Over the five fiscal years to FY2025 it shrank 39% a year on average.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025$0.71−79%
FY2024$3.33−17%
FY2023$4.00+11%
FY2022$3.59−33%
FY2021$5.32−38%
FY2020$8.53n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26$0.40−29%$0.77
Q1 FY26$0.55+67%$0.93
Q4 FY25−$0.79−288%$0.71
Q3 FY25$0.61−56%$1.92
Q2 FY25$0.56−25%$2.69
Q1 FY25$0.33−58%$2.88
Q4 FY24$0.42−80%$3.33
Q3 FY24$1.38+500%$5.04
Q2 FY24$0.75−21%$3.89
Q1 FY24$0.78+13%$4.09
Q4 FY23$2.13+407%$4.00
Q3 FY23$0.23−74%$2.29

Against its peers

Companies in Drug Manufacturers - General nearest Organon's size, closest first, today.

CompanyEPS, 12 monthsGrowth
OGNOrganon$0.77−71% a year
LQDALiquidia$1.39
ARQTArcutis Biotherapeutics$0.22
INDVIndivior Pharmaceuticals$2.78+227% a year
NRIXNurix Therapeutics$2.31
PBHPrestige Consumer Healthcare$3.57−16% a year
KNSAKiniksa Pharmaceuticals International$0.97+2325% a year
LGNDLigand Pharmaceuticals$9.40
HRMYHarmony Biosciences$3.09−0% a year
AMRXAmneal Pharmaceuticals$0.49+4800% a year
ALKSAlkermes plc.$0.38−82% a year
Peer median$1.85

Where Organon ranks

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Organon

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.